These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22699029)

  • 1. Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.
    Chang JS; Ha K; Yoon IY; Yoo CS; Yi SH; Her JY; Ha TH; Park T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):136-42. PubMed ID: 22699029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrative assessment of the psychophysiologic alterations in young women with recurrent major depressive disorder.
    Chang JS; Yoo CS; Yi SH; Her JY; Choi HM; Ha TH; Park T; Ha K
    Psychosom Med; 2012 Jun; 74(5):495-500. PubMed ID: 22408133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.
    Demyttenaere K; Hemels ME; Hudry J; Annemans L
    Clin Ther; 2005 Jan; 27(1):111-24. PubMed ID: 15763612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
    Grossman R; Reynolds D; Goodman M; New A; Silverman J; Schmeidler J; Mitropoulou V; Siever LJ
    Psychiatry Res; 2004 Sep; 128(2):203-6. PubMed ID: 15488964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.
    Bär KJ; Schuhmacher A; Höfels S; Schulz S; Voss A; Yeragani VK; Maier W; Zobel A
    J Affect Disord; 2010 Dec; 127(1-3):266-73. PubMed ID: 20538342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe forms of depression: the efficacy of escitalopram].
    Spadone C
    Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
    Montgomery SA; Huusom AK; Bothmer J
    Neuropsychobiology; 2004; 50(1):57-64. PubMed ID: 15179022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.
    Fernandez JL; Montgomery S; Francois C
    Pharmacoeconomics; 2005; 23(2):155-67. PubMed ID: 15748090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.
    Eckert L; Falissard B
    Curr Med Res Opin; 2006 Nov; 22(11):2313-21. PubMed ID: 17076991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.
    Sørensen J; Stage KB; Damsbo N; Le Lay A; Hemels ME
    Nord J Psychiatry; 2007; 61(2):100-8. PubMed ID: 17454724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
    Gründer G; Wetzel H; Schlösser R; Benkert O
    Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium and venlafaxine interaction: a case of serotonin syndrome.
    Adan-Manes J; Novalbos J; López-Rodríguez R; Ayuso-Mateos JL; Abad-Santos F
    J Clin Pharm Ther; 2006 Aug; 31(4):397-400. PubMed ID: 16882112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients.
    Song HR; Jung YE; Wang HR; Woo YS; Jun TY; Bahk WM
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):457-9. PubMed ID: 22834666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
    Simon JS; Aguiar LM; Kunz NR; Lei D
    J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.